Personal Facebook page https://www.facebook.com/EyadQunaibi ===== Twitter account https://twitter.com/Dr_EyadQun
Peace be upon you and the mercy of God and His blessings. There are medications that greatly resemble each other in their commercial names, which may lead to serious medical errors when handling them, whether by the pharmacist during dispensing or by the patient during use.
We posed a targeted question to medical professionals about a specific case: a patient suffering from Parkinson's disease who uses the medication Selegiline. This patient came down with a common cold, and the pharmacist dispensed a medication for him. The question is: Can this medication cause a serious drug interaction?
Unfortunately, less than 20% of the participants chose the correct answer, which is: Yes, this can lead to a very serious drug interaction.
The danger here lies in the similarity of the names with a difference of only one letter:
The difference between the two drugs is just the letter (R), so it is very important to pay close attention when reading the commercial names. We also call on pharmaceutical companies to avoid naming new drugs with names that greatly resemble those of previous drugs, to avoid these errors that may take the lives of patients.